Effect of rosmarinic acid on atopic dermatitis

Journal of Dermatology

Volumn 35, Issue 12, 2008, Pages 768-771

  Lee, Jongsung ^a,b   Jung, Eunsun ^a   Koh, Jassook ^c   Kim, Yeong Shik ^b   Park, Deokhoon ^a  

^a Biospectrum Life Science Institute   (South Korea)

^b Seoul National University   (South Korea)

^c Dermapro Ltd   (South Korea)

Author keywords

Atopic dermatitis; Pruritus; Rosmarinic acid; Transepidermal water loss

Indexed keywords

ROSMARINIC ACID;

ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRY SKIN; ELBOW; EMULSION; ERYTHEMA; EVENING DOSAGE; FEMALE; HUMAN; MALE; MORNING DOSAGE; PRESCHOOL CHILD; QUESTIONNAIRE; SCHOOL CHILD; SCORING SYSTEM; SKIN BURNING SENSATION; SKIN PRURITUS; SKIN WATER LOSS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CINNAMATES; DEPSIDES; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; OINTMENT BASES; YOUNG ADULT;

EID: 58149183903     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2008.00565.x     Document Type: Article

References (20)

1. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1968 102 : 128 137.
2. Bos JD, Wierenga O, Sillevis JH, Heijden FL, Kapsenberg ML. Immune dysregulation in atopic eczema. Arch Dermatol 1992 128 : 1509 1512.
3. Venge P. Eosinophil and neutrophil granulocytes. Allergy 1993 36 : 95 102.
4. Kirby B, Owen CM, Blewitt RW, Yates VM. Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapy. J Am Acad Dermatol 2002 : 47 (2 S165 S167.
5. Thomas MD, Cook LJ. Fever associated with cyclosporin for atopic dermatitis. Br Med J 1998 317 : 1291.
6. Van Meurs T, Wolkerstorfer A, Oranje AP. Extreme rises in serum alkaline phosphatase in children with atopic dermatitis after intervention treatment with cyclosporin A. Pediatr Dermatol 1998 15 (6 483.
7. Ambo M. Relapsing Kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis. Acta Dermato-Venereologica 2002 82 (3 224 225.
8. Fuchs M, Schliemann W, Heinemann C, Elsner P. Tacrolimus enhances irritation in a 5-day human irritancy in vivo model. Contact Dermatitis 2002 46 (5 290 294.
9. Al-Sereiti MR, Abu-Amer KM, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Expo Biol 1999 37 : 124 130.
10. Zheng W, Wang SY. Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem 2001 49 : 5165 5170.
11. Van Kessel, KP, Kalter ES. Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear granulocytes. J Verhoef Agents Actions 1986 17 : 375 376.
12. Sahu A, Rawal N, Pangburn MK. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b. Biochem Pharmacol 1999 : 57 : 1439 1446.
13. Kimura Y, Okuda H, Okuda T. Studies on the activities of tannins and related compounds, X: effects of caffeetannins and related compounds on arachidonate metabolism in human polymorphonuclear leukocytes. J Nat Prod 1987 50 : 392 399.
14. Kelm MA, Nair MG, Strasburg GM. Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Antioxidant Phytomedicine 2000 7 : 7 13.
15. Lee J, Jung E, Kim Y et al. Rosmarinic acid as a downstream inhibitor of IKK-beta in TNF-alpha-induced upregulation of CCL11 and CCR3. Br J Pharmacol 2006 148 (3 366 375.
16. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venerol (Stockh) 1980 92 (Suppl S44 S47.
17. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus reports of the European Task Force on atopic dermatitis. Dermatology 1993 186 : 23 31.
18. Yawalkar N, Uguccioni M, Scharer J et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999 113 : 43 48.
19. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003 9 : 575 581.
20. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002 3 : 221 227.